Associate Professor Tristan Rawling is a medicinal chemist and drug discovery researcher at the University of Technology Sydney, where he leads work on designing and synthesising new molecules that interact with cellular membranes and mitochondria to tackle major health challenges. He completed his PhD at UTS and followed this with postdoctoral research at the University of Sydney before returning to UTS to focus on developing compounds with potential applications in obesity, cancer, and metabolic disease by targeting how cells produce and use energy. His interdisciplinary approach blends chemical biology and medicinal chemistry to explore safer ways to modulate mitochondrial activity and improve metabolic health.